Liu G, Colangelo L, Ash S, San Jose Estepar R, Jacobs D, Thyagarajan B
ERJ Open Res. 2023; 9(3).
PMID: 37313396
PMC: 10259823.
DOI: 10.1183/23120541.00004-2023.
Liu H, Zhang X, Shao Y, Lin X, Dong F, Liu X
Bioengineered. 2021; 12(1):3113-3124.
PMID: 34187349
PMC: 8806824.
DOI: 10.1080/21655979.2021.1944020.
Oldham J, Vancheri C
Clin Chest Med. 2021; 42(2):263-273.
PMID: 34024402
PMC: 9075032.
DOI: 10.1016/j.ccm.2021.03.005.
Cheng Y, Wang Y, Dai L
Sleep Breath. 2021; 25(3):1219-1228.
PMID: 33403599
DOI: 10.1007/s11325-020-02282-z.
Sasaki H, Hara Y, Taguri M, Fujikura Y, Murohashi K, Yagyu H
Nagoya J Med Sci. 2020; 82(3):499-508.
PMID: 33132434
PMC: 7548256.
DOI: 10.18999/nagjms.82.3.499.
Dysregulation of club cell biology in idiopathic pulmonary fibrosis.
Zuo W, Rostami M, LeBlanc M, Kaner R, OBeirne S, Mezey J
PLoS One. 2020; 15(9):e0237529.
PMID: 32941426
PMC: 7498242.
DOI: 10.1371/journal.pone.0237529.
Emodin inhibiting neutrophil elastase-induced epithelial-mesenchymal transition through Notch1 signalling in alveolar epithelial cells.
Zhou L, Gao R, Hong H, Li X, Yang J, Shen W
J Cell Mol Med. 2020; 24(20):11998-12007.
PMID: 32935466
PMC: 7578861.
DOI: 10.1111/jcmm.15827.
Efficacy of recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Wang B, Li T
Exp Ther Med. 2020; 20(1):351-358.
PMID: 32537001
PMC: 7282169.
DOI: 10.3892/etm.2020.8709.
Increased flux through the mevalonate pathway mediates fibrotic repair without injury.
Larson-Casey J, Vaid M, Gu L, He C, Cai G, Ding Q
J Clin Invest. 2019; 129(11):4962-4978.
PMID: 31609245
PMC: 6819144.
DOI: 10.1172/JCI127959.
Transcriptional regulatory model of fibrosis progression in the human lung.
McDonough J, Ahangari F, Li Q, Jain S, Verleden S, Herazo-Maya J
JCI Insight. 2019; 4(22).
PMID: 31600171
PMC: 6948862.
DOI: 10.1172/jci.insight.131597.
Early and late preventive effect of on the bleomycin-induced pulmonary fibrosis in rats: An experimental study.
Poursalehi H, Fekri M, Sharifi Far F, Mandegari A, Izadi A, Mahmoodi R
Avicenna J Phytomed. 2018; 8(3):263-275.
PMID: 29881712
PMC: 5987441.
The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial.
Hammond M, Clark A, Cahn A, Chilvers E, Fraser W, Livermore D
Trials. 2018; 19(1):89.
PMID: 29402332
PMC: 5800095.
DOI: 10.1186/s13063-018-2453-6.
AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease.
Kaner R, Brown K, Martinez F
Am J Respir Crit Care Med. 2017; 195(9):1104-1107.
PMID: 28459330
PMC: 5803662.
DOI: 10.1164/rccm.201703-0584ED.
Idiopathic pulmonary fibrosis and a role for autoimmunity.
Hoyne G, Elliott H, Mutsaers S, Prele C
Immunol Cell Biol. 2017; 95(7):577-583.
PMID: 28356570
DOI: 10.1038/icb.2017.22.
Arterial Carboxyhemoglobin Measurement Is Useful for Evaluating Pulmonary Inflammation in Subjects with Interstitial Lung Disease.
Hara Y, Shinkai M, Kanoh S, Fujikura Y, Rubin B, Kawana A
Intern Med. 2017; 56(6):621-626.
PMID: 28321059
PMC: 5410469.
DOI: 10.2169/internalmedicine.56.7418.
Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis.
Vittal R, Mickler E, Fisher A, Zhang C, Rothhaar K, Gu H
PLoS One. 2013; 8(10):e76451.
PMID: 24204629
PMC: 3804565.
DOI: 10.1371/journal.pone.0076451.
Pulmonary fibrosis after pegylated liposomal Doxorubicin in a patient with uterine papillary serous carcinoma.
Nevadunsky N, Mbagwu C, Mizrahi N, Burton E, Goldberg G
J Clin Oncol. 2013; 31(10):e167-9.
PMID: 23358980
PMC: 4878101.
DOI: 10.1200/JCO.2012.44.5767.
Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis.
McGrath E, Lawrie A, Marriott H, Mercer P, Cross S, Arnold N
Thorax. 2012; 67(9):796-803.
PMID: 22496351
PMC: 3426075.
DOI: 10.1136/thoraxjnl-2011-200863.
Bronchoalveolar lavage and other methods to define the human respiratory tract milieu in health and disease.
Reynolds H
Lung. 2011; 189(2):87-99.
PMID: 21350888
DOI: 10.1007/s00408-011-9284-5.
Comprehensive lung injury pathology induced by mTOR inhibitors.
Aparicio G, Calvo M, Medina V, Fernandez O, Jimenez P, Lema M
Clin Transl Oncol. 2009; 11(8):499-510.
PMID: 19661024
DOI: 10.1007/s12094-009-0394-y.
